Microbiology and Immunology

You are here

Home > Publications > Publications

Publications

Found 259 results
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is F  [Clear All Filters]
2000
Fidock DA, Nomura T, Talley AK, Cooper RA, Dzekunov SM, Ferdig MT, Ursos LM, Sidhu AB, Naudé B, Deitsch KW et al..  2000.  Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance.. Mol Cell. 6(4):861-71.
Fidock DA, Nomura T, Talley AK, Cooper RA, Dzekunov SM, Ferdig MT, Ursos LM, Sidhu AB, Naudé B, Deitsch KW et al..  2000.  Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance.. Mol Cell. 6(4):861-71.
Peng Y, Falck-Pedersen E, Elkon KB.  2000.  Soluble CD8 attenuates cytotoxic T cell responses against replication-defective adenovirus affording transprotection of transgenes in vivo.. J Immunol. 165(3):1470-8.
Favis R, Day JP, Gerry NP, Phelan C, Narod S, Barany F.  2000.  Universal DNA array detection of small insertions and deletions in BRCA1 and BRCA2.. Nat Biotechnol. 18(5):561-4.
1999
Miyazawa N, Leopold PL, Hackett NR, Ferris B, Worgall S, Falck-Pedersen E, Crystal RG.  1999.  Fiber swap between adenovirus subgroups B and C alters intracellular trafficking of adenovirus gene transfer vectors.. J Virol. 73(7):6056-65.
Miyazawa N, Leopold PL, Hackett NR, Ferris B, Worgall S, Falck-Pedersen E, Crystal RG.  1999.  Fiber swap between adenovirus subgroups B and C alters intracellular trafficking of adenovirus gene transfer vectors.. J Virol. 73(7):6056-65.
Peng Y, Trevejo J, Zhou J, Marino MW, Crystal RG, Falck-Pedersen E, Elkon KB.  1999.  Inhibition of tumor necrosis factor alpha by an adenovirus-encoded soluble fusion protein extends transgene expression in the liver and lung.. J Virol. 73(6):5098-109.
Kaner RJ, Worgall S, Leopold PL, Stolze E, Milano E, Hidaka C, Ramalingam R, Hackett NR, Singh R, Bergelson J et al..  1999.  Modification of the genetic program of human alveolar macrophages by adenovirus vectors in vitro is feasible but inefficient, limited in part by the low level of expression of the coxsackie/adenovirus receptor.. Am J Respir Cell Mol Biol. 20(3):361-70.
Kaner RJ, Worgall S, Leopold PL, Stolze E, Milano E, Hidaka C, Ramalingam R, Hackett NR, Singh R, Bergelson J et al..  1999.  Modification of the genetic program of human alveolar macrophages by adenovirus vectors in vitro is feasible but inefficient, limited in part by the low level of expression of the coxsackie/adenovirus receptor.. Am J Respir Cell Mol Biol. 20(3):361-70.
Xiang Z, Hu XL, Flint J, Riethman HC.  1999.  A sequence-ready map of the human chromosome 17p telomere.. Genomics. 58(2):207-10.
1998
Gall JG, Crystal RG, Falck-Pedersen E.  1998.  Construction and characterization of hexon-chimeric adenoviruses: specification of adenovirus serotype.. J Virol. 72(12):10260-4.
Karp CL, Wysocka M, Ma X, Marovich M, Factor RE, Nutman T, Armant M, Wahl L, Cuomo P, Trinchieri G.  1998.  Potent suppression of IL-12 production from monocytes and dendritic cells during endotoxin tolerance.. Eur J Immunol. 28(10):3128-36.
Coughlin CM, Salhany KE, Gee MS, LaTemple DC, Kotenko S, Ma X, Gri G, Wysocka M, Kim JE, Liu L et al..  1998.  Tumor cell responses to IFNgamma affect tumorigenicity and response to IL-12 therapy and antiangiogenesis.. Immunity. 9(1):25-34.
1997
Mack CA, Song WR, Carpenter H, Wickham TJ, Kovesdi I, Harvey BG, Magovern CJ, Isom OW, Rosengart T, Falck-Pedersen E et al..  1997.  Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype.. Hum Gene Ther. 8(1):99-109.
Abrahamsen K, Kong HL, Mastrangeli A, Brough D, Lizonova A, Crystal RG, Falck-Pedersen E.  1997.  Construction of an adenovirus type 7a E1A- vector.. J Virol. 71(11):8946-51.
Moller DR, Wysocka M, Greenlee BM, Ma X, Wahl L, Flockhart DA, Trinchieri G, Karp CL.  1997.  Inhibition of IL-12 production by thalidomide.. J Immunol. 159(10):5157-61.
Worgall S, Wolff G, Falck-Pedersen E, Crystal RG.  1997.  Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration.. Hum Gene Ther. 8(1):37-44.
Ferguson DO, Rice MC, Rendi MH, Kotani H, Kmiec EB, Holloman WK.  1997.  Interaction between Ustilago maydis REC2 and RAD51 genes in DNA repair and mitotic recombination.. Genetics. 145(2):243-51.
Prescott JC, Liu L, Falck-Pedersen E.  1997.  Sequence-mediated regulation of adenovirus gene expression by repression of mRNA accumulation.. Mol Cell Biol. 17(4):2207-16.
Elkon KB, Liu CC, Gall JG, Trevejo J, Marino MW, Abrahamsen KA, Song X, Zhou JL, Old LJ, Crystal RG et al..  1997.  Tumor necrosis factor alpha plays a central role in immune-mediated clearance of adenoviral vectors.. Proc Natl Acad Sci U S A. 94(18):9814-9.
1996
Gall J, Kass-Eisler A, Leinwand L, Falck-Pedersen E.  1996.  Adenovirus type 5 and 7 capsid chimera: fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes.. J Virol. 70(4):2116-23.
Yoon SO, Lois C, Alvirez M, Alvarez-Buylla A, Falck-Pedersen E, Chao MV.  1996.  Adenovirus-mediated gene delivery into neuronal precursors of the adult mouse brain.. Proc Natl Acad Sci U S A. 93(21):11974-9.
Kass-Eisler A, Leinwand L, Gall J, Bloom B, Falck-Pedersen E.  1996.  Circumventing the immune response to adenovirus-mediated gene therapy.. Gene Ther. 3(2):154-62.
Chehimi J, Ma X, Chouaib S, Zyad A, Nagashunmugam T, Wojcik L, Chehimi S, Nissim L, Frank I.  1996.  Differential production of interleukin 10 during human immunodeficiency virus infection.. AIDS Res Hum Retroviruses. 12(12):1141-9.
Wolff G, Mastrangeli A, Heinflink M, Falck-Pedersen E, Gershengorn MC, Crystal RG.  1996.  Ectopic expression of thyrotropin releasing hormone (TRH) receptors in liver modulates organ function to regulate blood glucose by TRH.. Nat Genet. 12(3):274-9.